Taking people in GreeceNo phase
Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation
Key facts
- Who runs it
- University Hospital, Basel, Switzerland
- Where
- Pátrai, GreeceSee the siteAlso in 15 other countries, 24 sites
- Trial code
- Status
- Recruiting
- People taking part
- 15,000 people, planned
- Started
- 1 Jul 2024
- Expected to end
- 31 Dec 2028
- Type of study
- Observational
- Record updated
- 20 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Centers : Centers participating in the present collaborative study group. Invitation to participate will be based either upon personal referral of one of the investigator, previous collaboration or based on a meta-analytic review of the literature published on the subject within the past 20 years
- Patients: Females and males of >18 years undergoing any type of VT/PVC ablation. While we will accept redo-procedure we will ask for a unique patient-identifier to link procedures belonging to the same patients together
- Interventions: VT/PVC ablation (first intervention or re-do) as routinely performed by the participating centers
- Outcomes: Severe complications, defined as hemodynamic instability requiring mechanical intensive-care management, tamponade, stroke, cardiac arrest, myocardial infarction, phrenic nerve palsies, major bleeding requiring transfusion, vascular or cardiac complication requiring surgery, procedure-related death
- Setting: Observational cohort studies, registries, retrospective cohort studies. Data stemming from RCTs (Randomized controlled trials) will not be collected as they likely do not represent a "real-life" setting
- Length of follow-up: Peri-procedural complications
- Years considered: Not limited to a specific time-frame, but to reflect common ablation practices, we will focus on data from the 20 past years
- Number of patients provided : No lower limit of patients provided per dataset or ablation volume per year to include high- as well as low-volume centers
Who cannot take part
- Refusal of the center to participate
- Less than 10 procedures available in the dataset (no case reports)
- Missing essential baseline characteristics, missing collection of sufficient details regarding each complication
Where in Greece
Also in 15 other countries, 24 sites
- University of PatrasPátrai, GreeceContact: Georgios LeventopoulosTaking people
About the trial
What the trial wants to find out
The investigators aim to characterize patients presenting with a severe ventricular tachycardia (VT) and premature ventricular complex (PVC)-ablation-related complication including patient characteristics, procedural details and subsequent management of the complication by gathering existing patient-level data.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Severe Complications During Ventricular Tachycardia or Premature Ventricular Complex Ablation - an International Multicenter Collaborative Study Group
- Record updated
- 20 August 2026